Erector Spinae Plane Block in Patients Undergoing Minimally Invasive Lumbar Spine Surgery: A Randomized Controlled Trial
Hospital for Special Surgery, New York
Summary
This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
Description
Minimally invasive (MIS) spinal surgical procedures such as MIS transforaminal lumbar interbody fusion (TLIF) are being increasingly performed due to reduced morbidity. However, the mainstay for perioperative analgesia after these surgeries remains to be opioid pain medications, which have a number of associated adverse effects such as respiratory depression, hyperalgesia, and opioid habituation. Recently, the erector spinae plane (ESP) block has been introduced as an opioid-sparing regional anesthetic for lumbar spinal surgery with touted benefits including opioid use reduction and improved p…
Eligibility
- Age range
- 18–80 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Age 18-80 * Patients scheduled for MIS TLIF (any level) with the principal investigator * ASA 1, 2, 3 Exclusion Criteria: * ASA 4 or higher * BMI \>40 * Chronic opioid use (daily use for \> 3 months) * Revision surgery, any history of previous lumbar spine surgery * Allergy to any of the study medications * Non-English speaking * Chronic renal insufficiency or failure (creatinine \>2) or severe hepatic disease (cirrhosis, failure) * Pregnancy * Any concomitant surgery
Interventions
- ProcedureErector spinae plane (ESP) block
ESP block is an opioid-sparing regional anesthetic involving bupivacaine and dexamethasone for lumbar spinal surgery with touted benefits including opioid use reduction and improved pain control.
Location
- Hospital for Special SurgeryNew York, New York